Table 3.
Main Effect | Females (n = 78) | Males (n = 81) | |||||
---|---|---|---|---|---|---|---|
Exposure Measure | N | β Estimate | 95% Confidence Interval | β Estimate | 95% Confidence Interval | β Estimate | 95% Confidence Interval |
Phthalates (16–18 weeks gestation sample) 1 | |||||||
MEP (μg\L) | 158 | 0.3 | −0.3, 0.9 | 0.4 | −0.5, 1.2 | −2.5 | −4.4, −0.6 |
Σ DEHP (µmol/L) | 158 | 0.2 | −0.6, 1.1 | 0.5 | −0.6, 1.6 | −0.1 | −1.4, 1.2 |
Σ DINP (µmol/L) | 158 | 0.004 | −0.2, 0.2 | 0.06 | −0.1, 0.2 | −0.2 | −0.5, 0.2 |
Σ Anti-Androgenic (µmol/L) | 158 | −0.2 | −1.0, 0.6 | 0.02 | −0.9, 0.9 | −1.1 | −2.9, 0.7 |
Σ All phthalates (µmol/L) | 158 | 0.2 | −0.8, 1.1 | 0.7 | −0.3, 1.8 | −2.3 | −4.4, −0.2 |
Phthalates (Pooled sample) | |||||||
MEP (μg\L) | 159 | 0.3 | −0.3, 0.8 | 1 | 0.3, 1.7 | −1.9 | −4.2, 0.3 |
Σ DEHP (µmol/L) | 159 | 0.2 | −0.8, 1.2 | −0.7 | −2.6, 1.1 | 0.6 | −0.6, 1.7 |
Σ DINP 2 (µmol/L) | 158 | −0.3 | −0.7, 0.2 | 0.05 | −0.6, 0.7 | −1 | −1.8, −0.1 |
Σ Anti-Androgenic (µmol/L) | 159 | −0.3 | −1.0, 0.4 | −0.2 | −0.9, 0.5 | −1.2 | −3.5, 1.1 |
Σ All phthalates (µmol/L) | 159 | 0.04 | −0.8, 0.9 | 0.7 | −0.3, 1.7 | −1.7 | −3.2, −0.1 |
1 Phthalate metabolites for the 16–18-week urine were not available for one observation. 2 Model had a potential influential point removed (defined as Cook’s D values > 0.1). Values bolded were sex by exposure interaction was statistically significant (p-value < 0.05).